Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study

Post time The day before yesterday 00:14

journal：Dermatologic Surgery

Authors：Joon Seok; Young Gue Koh; Jun Ki Hong; So Hye Yun; Da Hye Kim; Hyung Seok Son; Sun Young Choi; Kwang Ho Yoo; Yang Won Lee; Beom Joon Kim

Published date：2024-6-

DOI：10.1097/dss.0000000000004146

PDF link：https://journals.lww.com/10.1097/DSS.0000000000004146

Article link：http://dx.doi.org/10.1097/dss.0000000000004146

Article Source：Ovid Technologies (Wolters Kluwer Health)。

Remark：

Post time Yesterday 08:39

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Ovid] Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Ovid] Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study Copy

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Ovid] Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study